Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Iacopetta

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|September 7, 2002
Are there two sides to colorectal cancer?Barry Iacopetta
Human Mutation|March 6, 2003
TP53 mutation in colorectal cancerBarry Iacopetta
Critical Reviews in Oncogenesis|November 3, 2006
Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracilBarry Iacopetta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapyMelinda Morris, Cameron Platell, Barry Iacopetta
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
Microsatellite instability in colorectal cancerBarry Iacopetta, Fabienne Grieu, Benhur Amanuel
Diseases of the Colon and Rectum|September 28, 2002
Extent of nodal involvement in Stage III colorectal carcinoma: relationship to clinicopathologic variables and genetic alterationsHany Elsaleh, Gábor Cserni, Barry Iacopetta
The Medical Journal of Australia|March 21, 2007
Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitalsMelinda Morris, Barry Iacopetta, Cameron Platell
Anticancer Research|August 19, 2007
A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancerMelinda Morris, Cameron Platell, Barry Iacopetta
Cancer Letters|July 21, 2005
DNA hypermethylation in breast cancer and its association with clinicopathological featuresShaoYing Li, Minna Rong, Barry Iacopetta
International Journal of Clinical Oncology|December 19, 2008
Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?Barry Iacopetta, Kazuyuki Kawakami, Toshiaki Watanabe
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|September 7, 2002
Are there two sides to colorectal cancer?Barry Iacopetta
Human Mutation|March 6, 2003
TP53 mutation in colorectal cancerBarry Iacopetta
Critical Reviews in Oncogenesis|November 3, 2006
Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracilBarry Iacopetta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapyMelinda Morris, Cameron Platell, Barry Iacopetta
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
Microsatellite instability in colorectal cancerBarry Iacopetta, Fabienne Grieu, Benhur Amanuel
Diseases of the Colon and Rectum|September 28, 2002
Extent of nodal involvement in Stage III colorectal carcinoma: relationship to clinicopathologic variables and genetic alterationsHany Elsaleh, Gábor Cserni, Barry Iacopetta
The Medical Journal of Australia|March 21, 2007
Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitalsMelinda Morris, Barry Iacopetta, Cameron Platell
Anticancer Research|August 19, 2007
A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancerMelinda Morris, Cameron Platell, Barry Iacopetta
Cancer Letters|July 21, 2005
DNA hypermethylation in breast cancer and its association with clinicopathological featuresShaoYing Li, Minna Rong, Barry Iacopetta
International Journal of Clinical Oncology|December 19, 2008
Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?Barry Iacopetta, Kazuyuki Kawakami, Toshiaki Watanabe
Pageof 8